Fund psilocybin therapy for someone who really needs it

Fund ground-breaking psilocybin treatment for patients in need

The OVID Clinic Berlin is one of only two clinics in Europe to be granted a compassionate use license, allowing it to legally treat up to 100 patients with psilocybin.
 
Our colleagues at OVID provide the psilocybin free of charge, the therapy comes at a cost of around €15,000 per person and is not covered by insurance. Any donations to MIND for this purpose will be used exclusively to find psilocybin treatments at OVID. Your donation could literally change someone's life. 
 
Every year, patients at our colleague's clinic undergo life-changing experiences that help them improve their lives. 
 
Psilocybin-assisted therapy is carried out under strict medical supervision and research oversight. 

Note: MIND Foundation is a registered non-profit organization. Your donation is tax-deductable.

Why psilocybin therapy offers hope to patients with severe treatment-resistant depression

Psilocybin therapy offers new hope to people with severe, treatment-resistant depression.
When administered in a safe, medically supervised environment with the support of a professional psychotherapists, psilocybin can temporarily increase brain plasticity and relax rigid patterns of thought associated with chronic depressive states. This creates an opportunity for profound therapeutic change, helping patients reconnect with their emotions, gain perspective, and rediscover their motivation for life.  
 
Clinical studies have demonstrated rapid and long-lasting improvements in many participants, even after a single session. Your donation helps to make this pioneering, evidence-based treatment accessible to patients who would otherwise have no opportunity to receive it.

Other ways to make an impact

TRAIN THE NEXT GENERATION OF THERAPISTS

Fund student scholarships of the APT Program indirectly help hundreds of patients

Learn more

BECOME A MEMBER OF THE MIND FOUNDATION

Your gateway to community, learning, and impact

Learn more

Subscribe to our Newsletter

MIND Newsletter

Newsletter